newest glp-1 medications for type 2 diabetes 2025 New Drug Approvals in 2025: What Clinicians Need to Know How GLP-1 medications are transforming

PlexusDx's Microdose GLP-1 Protocol begins at the gentlest starting point for patients wanting a slower titration, while standard semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of your dose escalation

The difference is convenience one vial instead of two, with both peptides in a fixed ratio

While research on this compound is still ongoing, preliminary studies have provided insights into its potential therapeutic applications and benefits

Conclusions/interpretation Our study provides novel evidence for the beneficial effect of GLP-1R agonists on WFS1-deficient human pancreatic beta cells and neurons, suggesting that these drugs may be considered as a treatment for individuals with Wolfram syndrome

Next, we turn to a major access milestone: the official launch of oral Wegovy, the first FDA-approved GLP-1 pill for obesity from Novo Nordisk